Skip to main content
Fig. 1 | Parasites & Vectors

Fig. 1

From: Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy

Fig. 1

Two-phase treatment protocol. The arrow on the left indicates the timing of scheduled rechecks. If the response based on history, clinical examination and clinicopathological variables was insufficient according to the attending veterinarian at the first recheck (at 3 months), a second antileishmanial drug was added, i.e. meglumine antimoniate or miltefosine. The treatment decision for the second antileishmanial drug was made by attending clinicians based on renal parameters, and also on owner preference. Additional rechecks were planned in severe cases

Back to article page